Tag
2 articles
Researchers evaluate Anthropic's AI-designed protein binders in experimental settings, highlighting the importance of target identity, expression titers, and consensus scoring in protein design workflows.
This article explains how AI-driven drug discovery works and why Insilico Medicine's advancement of an AI-discovered IPF treatment to Phase III trials represents a significant milestone in computational medicine.
